EUVIMEDDescubrir EUVIMED
Klinische StudieMixed-Methods-StudieOpen access

Development of a Voice-Activated Virtual Assistant to Improve Insomnia Among Young Adult Cancer Survivors: Mixed Methods Feasibility and Acceptability Study

Entwicklung eines sprachaktivierten virtuellen Assistenten zur Verbesserung von Insomnie bei jungen erwachsenen Krebsüberlebenden: Mixed-Methods-Feasibility- und Akzeptanzstudie

Hunter Groninger iD, Hannah Arem iD, Lylian Ayangma iD, Lisa Gong iD, Eric Zhou iD, Daniel Greenberg iD

JMIR Formative Research · 2025-03-10 · 9 · e64869

DOI: 10.2196/64869 ↗

Auf einen Blick

Bei 26 jungen erwachsenen Krebsüberlebenden mit Insomnie wurde ein sprachaktivierter, bildschirmfreier CBT-I-Prototyp getestet. Die Nutzung lag bei 94 % der vorgesehenen Zeiten und wurde als akzeptabel bewertet.

Fragestellung

Wie erleben junge erwachsene Krebsüberlebende ihre Insomnie, und ist ein sprachaktivierter, virtueller Assistent für CBT-I durchführbar und akzeptabel?

Methode

4 Fokusgruppen und anschließende einarmige Feasibility- und Akzeptanzstudie mit einem CBT-I-Prototypen zu Hause.

Ergebnisse

26 Teilnehmende nahmen an den Fokusgruppen teil. 12 testeten den Prototypen und nutzten ihn 94 % der zugewiesenen Zeiten (zweimal täglich für 14 Tage). Akzeptanzscore: 5,43.

Schlussfolgerung der Autor:innen

Junge erwachsene Krebsüberlebende waren mit dem sprachaktivierten CBT-I-Prototypen stark engagiert und fanden ihn akzeptabel. Nach der finalen Entwicklung sollten Wirksamkeitsstudien folgen.

Kernaussagen

  • 26 junge erwachsene Krebsüberlebende nahmen an Fokusgruppen teil
  • 12 testeten den Prototypen; Nutzung 94 % der vorgesehenen Zeiten
  • Akzeptanzscore 5,43; alle würden die Nutzung erneut empfehlen

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Klinische Studie in JMIR Formative Research, published online on 2025-03-10. Written by Hunter Groninger and 5 co-authors. Institution: MedStar Health Research Institute, Washington, DC, United States. Major MEDLINE topics: Cancer Survivors, Cognitive Behavioral Therapy, Sleep Initiation and Maintenance Disorders. Cited 11 times so far (Crossref); 52 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.

Auf einen BlickResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Background

Up to 75% of young adult cancer survivors (YACS) experience chronic insomnia, negatively affecting physical and emotional health and overall quality of life. Cognitive behavioral therapy for insomnia (CBT-I) is a gold-standard intervention to address insomnia. To improve CBT-I access and treatment adherence, screen-based digital CBT-I platforms have been developed. However, even with these digital products, widespread uptake of CBT-I remains limited, and new strategies for CBT-I delivery are warranted.

Objective

The objective of this study is to understand how YACS experience insomnia and how they might incorporate technology-delivered CBT-I into a daily routine and test the feasibility and acceptability of a novel screen-free voice-activated virtual assistant–delivered CBT-I prototype.

Methods

Eligible participants—ages 18-39, living with a history of cancer (any type, any stage), self-reporting on average less sleep than National Sleep Foundation recommendations, and English-speaking—were recruited from a major urban cancer center, 2 regional oncology clinics, and 2 cancer survivorship support groups. We conducted 4 focus groups to understand the YACS experience of insomnia, their routine use of technology at home, particularly voice-activated virtual assistants such as Amazon Alexa, and input on how CBT-I might be delivered at home through a smart speaker system. We developed a prototype device to deliver key elements of CBT-I at home along with circadian lighting and monitoring of post-bedtime device use, collected YACS user perspectives on this prototype, and then conducted a single-arm feasibility and acceptability study.

Results

In total, 26 YACS (6-7 participants per group) experiencing insomnia participated in focus groups to share experiences of insomnia during cancer survivorship and to provide input regarding a CBT-I prototype. Common triggers of insomnia included worry about disease management and progression, disease-related pain and other symptoms, choices regarding personal device use, and worry about the impact of poor sleep on daily functioning. In total, 12 participants completed device prototype testing, engaging with the prototype 94% of the assigned times (twice daily for 14 days; meeting predetermined feasibility cutoff of engagement ≥70% of assigned times) and rating the prototype with an overall mean score of 5.43 on the Satisfaction subscale of the Usability, Satisfaction, and Ease of Use scale (range 4.42-7; exceeding the predetermined cutoff score for acceptability of 5.0). All participants completing the study reported they would be interested in using the prototype again and would recommend it to someone else with insomnia.

Conclusions

YACS were highly engaged with our voice-activated virtual assistant–delivered CBT-I prototype and found it acceptable to use. Following final device development, future studies should evaluate the efficacy of this intervention among YACS. Trial Registration ClinicalTrials.gov NCT05875129; https://clinicaltrials.gov/study/NCT05875129

Subjects

MeSH terms (MEDLINE)

Cancer SurvivorsCognitive Behavioral TherapySleep Initiation and Maintenance DisordersAdolescentAdultFemaleHumansMaleYoung AdultFeasibility StudiesFocus GroupsPatient Acceptance of Health CareQuality of Life

Author keywords

CBTappartificial intelligencecancercognitive behavioral therapyfocus groupinsomniamHealthmobile healthoncologyqualitative researchsleepsurvivortechnologyvirtual assistants

Authors and institutions

  • MedStar Health Research Institute, Washington, DC, United States.
  • MedStar Washington Hospital Center, Washington, DC, United States.
  • Georgetown University School of Medicine, Washington, DC, United States.
  • MedStar Health Research Institute, Hyattsville, MD, United States.
  • Dana Farber Cancer Institute, Boston, MA, United States.
  • MediaRez LLC, Washington, DC, United States.

ORCID profiles: Hunter Groninger, Hannah Arem, Lylian Ayangma, Lisa Gong, Eric Zhou, Daniel Greenberg

Funding

  • NCI NIH HHS

Cite

APA

Groninger, H., Arem, H., Ayangma, L., Gong, L., Zhou, E., & Greenberg, D. (2025). Development of a Voice-Activated Virtual Assistant to Improve Insomnia Among Young Adult Cancer Survivors: Mixed Methods Feasibility and Acceptability Study. JMIR Formative Research, 9, e64869. https://doi.org/10.2196/64869

Vancouver

Groninger H, Arem H, Ayangma L, Gong L, Zhou E, Greenberg D. Development of a Voice-Activated Virtual Assistant to Improve Insomnia Among Young Adult Cancer Survivors: Mixed Methods Feasibility and Acceptability Study. JMIR Formative Research. 2025;9:e64869. doi:10.2196/64869

BibTeX
@article{Groninger2025,
  author = {Groninger, Hunter and Arem, Hannah and Ayangma, Lylian and Gong, Lisa and Zhou, Eric and Greenberg, Daniel},
  title = {Development of a Voice-Activated Virtual Assistant to Improve Insomnia Among Young Adult Cancer Survivors: Mixed Methods Feasibility and Acceptability Study},
  journal = {JMIR Formative Research},
  year = {2025},
  volume = {9},
  pages = {e64869},
  doi = {10.2196/64869}
}
Start for free →